Regulatory Approvals

Galaxy Therapeutics’ SEAL embolization system gets CE mark

By

Regulatory Approvals — Galaxy Therapeutics’ SEAL embolization system gets CE mark  MassDevice

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 5, 2026.

By

Related Post

Regulatory Approvals

FDA Approves Jideytro for Previously Treated ROS1-Positive Lung Cancer

Regulatory Approvals

Tip Sheet: Experts discover fibromyalgia risk factors; FDA approves new breast cancer drug — and public health genome platform expands to new phase

Regulatory Approvals

FDA approves Charlotte company’s drug for cardiac disorder affecting thousands of patients

Financial News For All

Litigation

Rackspace Technology, executives named in securities fraud lawsuit over AI strategy

Mergers & Acquisitions

Paramount “Fully Expects” WBD Merger To Close As It Reports Q2 Streaming Gains, Linear Challenges

Mergers & Acquisitions

David Ellison claims opposition to his mega-merger stems from potential CNN control

Mergers & Acquisitions

Judge Sets Paramount-Warner Bros. Merger Trial for March